Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 5 of 5
Full-Text Articles in Life Sciences
Induction Of Ip-10 By Sars-Cov Infection Of Calu-3cells And Balb/C Mice, Y. Kumaki, C. W. Day, K. W. Bailey, M. H. Wong, M. K. Wandersee, R. Madsen, J. S. Madsen, N. M. Nelson, J. D. Hoopes, J. D. Woolcott, Z. T. Mclean, L. M. Blatt, A. M. Salazar, Dale L. Barnard
Induction Of Ip-10 By Sars-Cov Infection Of Calu-3cells And Balb/C Mice, Y. Kumaki, C. W. Day, K. W. Bailey, M. H. Wong, M. K. Wandersee, R. Madsen, J. S. Madsen, N. M. Nelson, J. D. Hoopes, J. D. Woolcott, Z. T. Mclean, L. M. Blatt, A. M. Salazar, Dale L. Barnard
Animal, Dairy, and Veterinary Science Faculty Publications
Destruction of the architectural and subsequently the functional integrity of the lung following pulmonary viral infections is attributable to both the extent of pathogen replication and to the host-generated inflammation associated with the recruitment of immune responses. The presence of antigenically disparate pulmonary viruses and the emergence of novel viruses assures the recurrence of lung damage with infection and resolution of each primary viral infection. Thus, there is a need to develop safe broad spectrum immunoprophylactic strategies capable of enhancing protective immune responses in the lung but which limits immune-mediated lung damage. The immunoprophylactic strategy described here utilizes a protein …
A New Mouse-Adapted Strain Of Sars-Cov As A Lethal Model Forevaluating Antiviral Agents In Vitro And In Vivo, C. W. Day, R. Baric, S. X. Cai, M. Frieman, Y. Kumaki, John D. Morrey, Donald F. Smee, Dale L. Barnard
A New Mouse-Adapted Strain Of Sars-Cov As A Lethal Model Forevaluating Antiviral Agents In Vitro And In Vivo, C. W. Day, R. Baric, S. X. Cai, M. Frieman, Y. Kumaki, John D. Morrey, Donald F. Smee, Dale L. Barnard
Animal, Dairy, and Veterinary Science Faculty Publications
Severe acute respiratory syndrome (SARS) is a highly lethal emerging disease caused by coronavirus SARS-CoV. New lethal animal models for SARS were needed to facilitate antiviral research. We adapted and characterized a new strain of SARS-CoV (strain v2163) that was highly lethal in 5–6 week old BALB/c mice. It had nine mutations affecting 10 amino acid residues. Strain v2163 increased IL-1α, IL-6, MIP-1α, MCP-1, and RANTES in mice, and high IL-6 expression correlated with mortality. The infection largely mimicked human disease, but lung pathology lacked hyaline membrane formation. In vitro efficacy against v2163 was shown with known inhihibitors of SARSCoV …
Is The Anti-Psychotic, 10-(3-(Dimethylamino)Propyl)Phenothiazine (Promazine), A Dangerous Drug With Which To Treatsars Infections? Efficacy Of Promazine On Sars-Cov Replication In A Mouse Model, Dale L. Barnard, C. W. Day, K. Bailey, M. Heiner, R. Montgomery, L. Lauridsen, K. H. Jung, P. K. Chan, J. K. Li, R. W. Sidwell
Is The Anti-Psychotic, 10-(3-(Dimethylamino)Propyl)Phenothiazine (Promazine), A Dangerous Drug With Which To Treatsars Infections? Efficacy Of Promazine On Sars-Cov Replication In A Mouse Model, Dale L. Barnard, C. W. Day, K. Bailey, M. Heiner, R. Montgomery, L. Lauridsen, K. H. Jung, P. K. Chan, J. K. Li, R. W. Sidwell
Animal, Dairy, and Veterinary Science Faculty Publications
Phenothiazine and derivatives were tested for inhibition of SARS-CoV replication. Phenothiazine slightly inhibited SARS-CoV replication in a neutral red (NR) uptake assay. Adding a propylamino group to give promazine reduced virus yields (VYR assay) with an EC90 = 8.3 ± 2.8 μM, but without selectivity. Various substitutions in the basic phenothiazine structure did not promote efficacy. Phenazine ethosulfate was the most potent compound by VYR assay (EC90 = 6.1 ± 4.3 μM). All compounds were toxic (IC50 = 6.6–74.5 μM) except for phenoxathiin (IC50 = 858 ± 208 μM) and 10-(alpha-diethylamino-propionyl) phenothiazine·HCl (IC50 = 195 ± 71.2 μM). Consequently, none …
Interferon Alfacon 1 Inhibits Sars-Covinfection In Human Bronchial Epithelial Calu-3 Cells, Y. Kumaki, C. W. Day, M. K. Wandersee, B. P. Schow, J. S. Madsen, D. Grant, J. P. Roth, Donald F. Smee, L. M. Blatt, Dale L. Barnard
Interferon Alfacon 1 Inhibits Sars-Covinfection In Human Bronchial Epithelial Calu-3 Cells, Y. Kumaki, C. W. Day, M. K. Wandersee, B. P. Schow, J. S. Madsen, D. Grant, J. P. Roth, Donald F. Smee, L. M. Blatt, Dale L. Barnard
Animal, Dairy, and Veterinary Science Faculty Publications
The primary targets for SARS-CoV infection are the epithelial cells in the respiratory and intestinal tract. The angiotensin-converting enzyme 2 (ACE-2) has been identified as a functional receptor for SARS-CoV. ACE-2 has been shown to be expressed at the apical domain of polarized Calu-3 cells. In this report, interferon alfacon 1 was examined for inhibitory activities against SARS-CoV on human lung carcinoma epithelial Calu-3 cell line and the other three African green monkey kidney epithelial cell lines. Interferon alfacon 1 demonstrated significant antiviral activity in neutral red uptake assay and virus yield reduction assay. The data might provide an important …
Evaluation Of Immunomodulators, Interferons And Known In Vitro Sars-Cov Inhibitors For Inhibition Of Sars-Cov Replication In Balb/C Mice, Dale L. Barnard, C. W. Day, K. Bailey, M. Heiner, R. Montgomery, L. Lauridsen, P. K-S. Chan, R. W. Sidwell
Evaluation Of Immunomodulators, Interferons And Known In Vitro Sars-Cov Inhibitors For Inhibition Of Sars-Cov Replication In Balb/C Mice, Dale L. Barnard, C. W. Day, K. Bailey, M. Heiner, R. Montgomery, L. Lauridsen, P. K-S. Chan, R. W. Sidwell
Animal, Dairy, and Veterinary Science Faculty Publications
Compounds approved for therapeutic use and in vitro inhibitors of severe acute respiratory syndrome coronavirus (SARS-CoV) were evaluated for inhibition in the mouse SARS-CoV replication model. A hybrid interferon, interferon alpha (IFN-alpha) B/D, and a mismatched double-stranded (ds) RNA interferon (IFN) inducer, Ampligen® (poly I:poly C124), were the only compounds that potently inhibited virus titres in the lungs of infected mice as assessed by CPE titration assays. When mice were dosed intraperitoneally (i.p.) with IFN-alpha B/D once daily for 3 days beginning 4 h after virus exposure, SARS-CoV replication in the lungs of infected mice was reduced by 1 log10 …